sponsored links

Lazanda Approved for Cancer Pain (HealthDay)

Sponsored Links

HealthDay – FRIDAY, July 1 (HealthDay News) — Lazanda (fentanyl) nasal spray has been approved by the U. S. Food and Drug Administration to treat breakthrough pain in adults with cancer who are already receiving opioid therapy, drug maker Archimedes Pharma said.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.